Celldex Therapeutics (NASDAQ:CLDX) Receives New Coverage from Analysts at TD Cowen
TD Cowen started coverage on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat reports. The firm issued an outperform rating on the biopharmaceutical company’s stock. Several other analysts have also recently weighed in on CLDX. HC Wainwright raised their price objective on shares of […]
More Stories
Artemis II Mission Ends With Splashdown Off San Diego
By T.J. Muscaro HOUSTON—Humanity’s first adventure to the moon in more than 50 years is complete. Artemis II, NASA’s 10-day...
Trump Warns Iran Has ‘No Cards’ Except Strait of Hormuz in Peace Talks
By Jack Phillips President Donald Trump on Friday said that the Iranian regime has very few negotiating options ahead of...
State Department Settles Lawsuit Alleging It Censored Conservative Outlets Under Biden
By Jacki Thrapp The Department of Justice (DOJ) settled a lawsuit that accused the Biden administration of censoring speech by...
Supreme Court Upholds Reversal of Death Declaration in Case of Man Found to Be Alive
By The Canadian Press The Supreme Court of Canada has affirmed a judge’s decision to annul the declaration of a...
US Annual Inflation Shoots Up to 3.3 Percent, Highest Level Since May 2024
By Andrew Moran A spike in energy prices sent the annual U.S. inflation rate to its highest level since May...
Iran Declares Strait of Hormuz Open, but Warns of Risk From Mines
By Chris Summers Iran said on April 9 that the Strait of Hormuz is open to all civilian shipping but...